Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 5.96x is 80% below its 5-year average of 29.27x, near the low end of its 5-year range (5.96x–288.50x).
As of the fiscal period ended Tuesday, June 30, 2026. 69.90% below its 12-month average of 19.80x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
5.96x
INTEREST COVERAGE RATIO AVG TTM
19.80x
INTEREST COVERAGE RATIO AVG 3Y
11.01x
INTEREST COVERAGE RATIO AVG 5Y
14.71x
INTEREST COVERAGE RATIO AVG 10Y
10.14x
INTEREST COVERAGE RATIO AVG 15Y
12.12x
INTEREST COVERAGE RATIO AVG 20Y
10.48x
CURRENT VS TTM AVG
-69.90%
CURRENT VS 3Y AVG
-45.89%
CURRENT VS 5Y AVG
-59.48%
CURRENT VS 10Y AVG
-41.20%
CURRENT VS 15Y AVG
-50.84%
CURRENT VS 20Y AVG
-43.14%
SECTOR MEDIAN · HEALTHCARE
6.77x
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
-11.97%
vs the sector median at left
Abbott Laboratories
Market Cap
$182.90B
Interest Coverage Ratio
5.96x
TTM Avg
19.80x
3Y Avg
11.01x
5Y Avg
14.71x
Market Cap
$161.66B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$207.87B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$209.19B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$213.42B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$142.54B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$137.13B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$133.37B
Interest Coverage Ratio
8.41x
TTM Avg
6.69x
3Y Avg
7.04x
5Y Avg
6.41x
Market Cap
$133.25B
Interest Coverage Ratio
3.33x
TTM Avg
3.10x
3Y Avg
3.72x
5Y Avg
4.16x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | $182.90B | 5.96x | 19.80x | 11.01x | 14.71x |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 11.43x | 6.56x | 7.26x | 7.18x |
| Amgen Inc. (AMGN)vs › | $207.87B | 3.88x | 3.09x | 3.93x | 4.89x |
| Novo Nordisk A/S (NVO)vs › | $209.19B | 30.34x | 54.30x | 123.94x | 139.58x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 5.71x | 5.17x | 6.77x | 10.10x |
| Pfizer Inc. (PFE)vs › | $142.54B | 5.78x | 5.55x | 10.96x | 11.04x |
| Danaher Corporation (DHR)vs › | $137.13B | 19.38x | 19.02x | 23.18x | 23.65x |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 8.41x | 6.69x | 7.04x | 6.41x |
| CVS Health Corp. (CVS)vs › | $133.25B | 3.33x | 3.10x | 3.72x | 4.16x |
| AstraZeneca PLC (AZN)vs › | $131.47B | 8.11x | 7.03x | 5.51x | 4.49x |
Interest Coverage
6.0x
Debt/Equity
0.29
Current Ratio
1.58
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 5.96x |
| 2026-03-31 | 10.59x |
| 2025-12-31 | 18.76x |
| 2025-09-30 | 46.75x |
| 2025-06-30 | 16.96x |
| 2025-03-31 | 12.60x |
| 2024-12-31 | 13.09x |
| 2024-09-30 | 10.95x |
| 2024-06-30 | 10.04x |
| 2024-03-31 | 11.84x |
| 2023-12-31 | 7.93x |
| 2023-09-30 | 11.34x |
| 2023-06-30 | 9.88x |
| 2023-03-31 | 8.64x |
| 2022-12-31 | 8.79x |
| 2022-09-30 | 30.41x |
| 2022-06-30 | 27.45x |
| 2022-03-31 | 288.50x |
| 2021-12-31 | 27.49x |
| 2021-09-30 | 22.03x |
| 2021-06-30 | 14.69x |
| 2021-03-31 | 32.32x |
| 2020-12-31 | 21.18x |
| 2020-09-30 | 11.56x |
| 2020-06-30 | 3.99x |
| 2020-03-31 | 2.54x |
| 2019-12-31 | 10.18x |
| 2019-09-30 | 5.95x |
| 2019-06-30 | 4.51x |
| 2019-03-31 | 3.55x |
| 2018-12-31 | 4.39x |
| 2018-09-30 | 6.52x |
| 2018-06-30 | 5.29x |
| 2018-03-31 | 5.55x |
| 2017-12-31 | 3.52x |
| 2017-09-30 | 4.17x |
| 2017-06-30 | 1.70x |
| 2017-03-31 | -0.33x |
| 2016-09-30 | 13.70x |
| 2016-06-30 | 7.92x |
| 2016-03-31 | 9.03x |
| 2015-12-31 | 19.88x |
| 2015-09-30 | 17.39x |
| 2015-06-30 | 16.57x |
| 2015-03-31 | 16.49x |
| 2014-12-31 | 19.28x |
| 2014-09-30 | 20.89x |
| 2014-06-30 | 18.81x |
| 2014-03-31 | 10.14x |
| 2013-12-31 | 21.08x |
| 2013-09-30 | 12.78x |
| 2013-06-30 | 15.68x |
| 2013-03-31 | 15.00x |
| 2012-12-31 | 12.96x |
| 2012-09-30 | 2.04x |
| 2012-06-30 | 6.77x |
| 2012-03-31 | 6.20x |
| 2011-12-31 | 16.52x |
| 2011-09-30 | 4.79x |
| 2011-06-30 | 13.22x |
| 2011-03-31 | 8.94x |
| 2010-12-31 | 12.09x |
| 2010-09-30 | 7.92x |
| 2010-06-30 | 11.94x |
| 2010-03-31 | 12.44x |
| 2009-12-31 | 15.04x |
| 2009-09-30 | 12.18x |
| 2009-06-30 | 12.20x |
| 2009-03-31 | 8.54x |
| 2008-12-31 | 3.30x |
| 2008-09-30 | 11.17x |
| 2008-06-30 | 10.21x |
| 2008-03-31 | 8.05x |
| 2007-12-31 | 2.56x |
| 2007-09-30 | 6.32x |
| 2007-06-30 | 7.74x |
| 2007-03-31 | 6.43x |
| 2006-12-31 | -0.87x |
| 2006-09-30 | 0.01x |
| 2006-06-30 | 0.01x |
| 2006-03-31 | 30.83x |
| 2005-12-31 | 8.47x |
| 2005-09-30 | 20.58x |
| 2005-06-30 | 25.32x |
| 2005-03-31 | 26.87x |
| 2004-12-31 | 7.57x |
| 2004-09-30 | 27.86x |
| 2004-06-30 | 22.82x |
| 2004-03-31 | 26.88x |
| 2003-12-31 | 7.57x |
| 2003-09-30 | 22.66x |
| 2003-06-30 | 5.95x |
| 2003-03-31 | 26.29x |
| 2002-12-31 | 4.33x |
| 2002-09-30 | 0.02x |
